Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuromodulation ; 20(7): 727-732, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28234408

RESUMO

OBJECTIVES: This study describes the training, experience with pocket fills, and life-long learning behaviors in a national sample of health care professionals who perform the reservoir refill procedure and compares results with intraspinal drug delivery morbidity and mortality clinical practice guidelines to demonstrate the need for standardized training. METHODS: Using a cross-sectional, descriptive design and a 23-item questionnaire administered via social media, 65 health care professionals who performed the reservoir refill procedure within the last year were surveyed. Descriptive and inferential statistics were used for analysis. RESULTS: Our results showed: 1) training varied widely and lacked supervision and mentoring for the inexperienced clinician, 2) the highest number of pocket fills was reported by the most experienced clinicians, and 3) there was limited participation in professional meetings where intraspinal therapy is discussed. The use of intraspinal drug delivery clinical practice guidelines significantly increased in current practice compared to use during training. CONCLUSION: Training for the reservoir refill procedure was highly variable, inconsistent with intraspinal drug delivery clinical practice guidelines' training recommendations with a high number of pocket fills, and low participation in national intraspinal drug delivery meetings. Standardized training is needed to reduce variability and minimize the risk for human error during the reservoir refill procedure.


Assuntos
Analgésicos/administração & dosagem , Pessoal de Saúde/educação , Bombas de Infusão Implantáveis , Adulto , Idoso , Estudos Transversais , Feminino , Humanos , Injeções Espinhais , Masculino , Pessoa de Meia-Idade , Dor Intratável/tratamento farmacológico , Inquéritos e Questionários
2.
Reg Anesth Pain Med ; 39(1): 73-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24310045

RESUMO

OBJECTIVE: We report 2 cases of spinal epidural hematoma formation after the removal of percutaneous spinal cord stimulator trial leads and discuss the possible etiologies of these complications. CASE REPORT: Two patients developed spinal epidural hematomas shortly after removal of their percutaneous trial leads and required multilevel laminectomies for evacuation of the hematoma. Patient 1 reported taking aspirin the morning that his leads were pulled, whereas patient 2 had not taken aspirin in the 7 days before commencing his trial. There were 2 days between identification and evacuation of patient 1's hematoma, and he did not fully recover from the injury to his spinal cord. Patient 2 underwent surgery immediately with complete resolution of his symptoms. CONCLUSIONS: Currently, the neuromodulation community ascribes to the American Society of Regional Anesthesia and Pain Medicine guidelines, which state that nonsteroidal anti-inflammatory drugs do not significantly increase the risk for epidural hematoma with neuraxial anesthesia and, therefore, there is no need to discontinue these drugs before epidural or spinal anesthesia. We suggest that these guidelines may not be appropriate for neuromodulatory techniques that likely subject the surrounding vasculature to more trauma than neuraxial anesthesia. We recommend discontinuing nonsteroidal anti-inflammatory drugs, particularly aspirin, before neuromodulation procedures. Further investigation will establish a timeframe for holding these drugs to optimize patient safety.


Assuntos
Aspirina/efeitos adversos , Remoção de Dispositivo/efeitos adversos , Hematoma Epidural Espinal/diagnóstico por imagem , Estimulação da Medula Espinal/efeitos adversos , Idoso , Anti-Inflamatórios não Esteroides/efeitos adversos , Ensaios Clínicos como Assunto , Hematoma Epidural Espinal/induzido quimicamente , Hematoma Epidural Espinal/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Radiografia , Estimulação da Medula Espinal/instrumentação , Fatores de Tempo
3.
Pain Pract ; 11(1): 103-6, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-20642486

RESUMO

BACKGROUND: Implanted delivery systems for intrathecal drug administration have become more common in the management of nonmalignant pain. Many postprocedural complications have been described in the literature including infection and headache provoked by position changes. Determining the etiology of a postimplant headache is important particularly when considering the possibility of a life-threatening infection. CASE REPORT: We present a patient who underwent placement of an implantable drug delivery system (IDDS) for intractable abdominal pain that developed positional headaches, and significant neck and back pain. Attempted cerebrospinal fluid aspiration reproduced her symptoms and imaging revealed a malpositioned intraspinal catheter tip approximated to the meninges. Revision of the system completely relieved her symptoms. CONCLUSION: Meningismus from malpositioned catheters is a rare complication that can mimic meningitis but should be considered in the differential for postimplant headaches. Given the increased use of IDDS, it is important to recognize and evaluate postimplant complication and treat it appropriately. We discuss this case report and appropriate work-up and differential diagnosis for meningismus following implant.


Assuntos
Catéteres/efeitos adversos , Bombas de Infusão Implantáveis/efeitos adversos , Meningismo/etiologia , Dor Abdominal/tratamento farmacológico , Adulto , Feminino , Humanos , Imageamento por Ressonância Magnética , Medula Espinal/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...